We believe that ureteral stenting is an excellent solution for acute ureteral obstruction following Dextranomer/hyaluronic acid polymer injection
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Ureteral obstruction following bulking agent injection for treatment of vesicoureteral reflux is rare.
📊
Key Findings & Data:The stents were removed 4 weeks later with complete resolution of the obstruction.
💡
Conclusion & Impact:We believe that ureteral stenting is an excellent solution for acute ureteral obstruction following Dextranomer/hyaluronic acid polymer injection
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Ureteral obstruction following bulking agent injection for treatment of vesicoureteral reflux is rare. Herein we report a case of acute bilateral ureteral obstruction following bilateral Dextranomer/hyaluronic acid polymer injection. The obstruction which manifested hours following the injection, was treated with prompt insertion of bilateral ureteral stents. The stents were removed 4 weeks later with complete resolution of the obstruction. We believe that ureteral stenting is an excellent solution for acute ureteral obstruction following Dextranomer/hyaluronic acid polymer injection
🔖
Cite This Article
LAVİ, A., TZEMAH, S., MASHİAH, A., KATZ, Z., COHEN, M. (2017). PEDIATRIC UROLOGY CASE REPORTS Ped Urol Case Rep. Pediatric Urology Case Reports, Cilt: 4 - Sayı: 3, 333–336. https://ajindex.com/articles/285619
Molitierno JA, Scherz HC, Kirsch AJ. Endoscopic treatment of vesicoureteral reflux using dextranomer hyaluronic acid copolymer. J Pediatr Urol. 2008;4(3):221-8. [2]Biočíc M, Todoríc J, Budimir D et al. Endoscopic treatment of vesicoureteral reflux in children with subureteral dextranomer/hyaluronic acid injection: a single-centre, 7-year experience. Can J Surg. 2012; 55(5): 301–6. [3]Pinto KJ, Pugach J, Saalfield J. Lack of usefulness of positioned instillation of contrast cystogram after injection of dextranomer/hyaluronic acid. J Urol. 2006;176 (6 Pt 1):2654–6. [4]Yu RN, Roth DR. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon. Pediatrics. 2006;118(8):698–703. [5]Vandersteen DR, Routh JC, Kirsch AJ, et al. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic acid copolymer. J Urol. 2006;176 (4 Pt 1):1593-5. [6]Scarpa AA1, Del Rossi C, Casolari E, Gatti C, Scarpa AG. Endoscopic treatment of vesicoureteric reflux in paediatric patient: results of a long-term study. Acta Biomed. 2011;82(2):137-45. [7]Khoury AE, Bagli DJ. Vesicoureteral reflux. In: Wein A; Kavoussi LR, Partin AW et al, eds. Campbell-Walsh Urology 11th edition. Philadelphia: Elsevier Sanders; 2015:3134-3172. [8]Cambareri G, Hanna M, Stock J. Practice patterns among pediatric urologists in the use of Deflux® for vesicoureteral reflux: a survey. J Pediatr Urol. 2013;9(6 Pt A):955- 61. [9]Snodgrass, W. Obstruction of a dysmorphic ureter following dextranomer/hyaluronic acid copolymer. J Urol, 171: 395, 2004. [10]Baybikov R, Sizonov V, Bondarenko S et al. Treatment of uretral obstruction after endoscopic injection in vesicouretral reflux. 26TH congress ESPU Praque, Czech Republic, 14-17th October 2015. S4-8. [11]Nseyo U, Mancini JG, Wiener JS. Symptomatic bilateral delayed partial ureteral obstruction after bilateral endoscopic correction of vesicoureteral reflux with dextranomer/hyaluronic acid polymer. Urology. 2013;81(1):184-7.